In a world that often overlooks the challenges faced by those with rare diseases, Rare Disease Day serves as a beacon of hope, a day dedicated to raising awareness and advocating for change. With 300 million people worldwide grappling with rare diseases, the need for collective action is more crucial than ever.
If you are ready to take your drug development program to the next level, we encourage you to join us in Boston for the upcoming TACT meeting. Seize this opportunity to engage with top-tier experts, refine your strategy, and propel your therapeutic innovation forward.
TREAT-NMD is honoured to be a media partner for this years World Orphan Drug Congress USA 2024 being held at the Boston Convention & Exhibition Centre from April 23 to April 25, 2024.
We are now accepting applications for our Masterclass Event 2024 in Dubai, UAE. This event is primarily for healthcare professionals, clinical researchers and allied health providers working in the Middle East region.
TREAT-NMD are proud to announce the launch of the PaLaDIn project, an incredibly exciting and ambitious new project that aims to accelerate research, understanding and treatment for neuromuscular and other rare diseases.
TREAT-NMD will be attending the Parent Project aps 21st International Conference on Duchenne and Becker Muscular Dystrophy in Rome. CEO, David Allison, and Neil Bennett, Head of Real World Evidence will be discussing the PaLaDIn project, and ‘The Interactium’ an innovative platform for data collection.